top of page
RESEARCH ARTICLES
Scientific perspectives on electric field therapy as integrated complementary cancer care
Section Title
Immune Modulation in Cancer: The Role of Tumor Treating Fields
The aim of this research is to understand how low-intensity alternating electric fields affect cancer not only by slowing tumor cell division, but also by helping the body’s own immune system recognize and respond to cancer more effectively.
The schemes, mechanisms and molecular pathway changes of Alternating Electric Fields alone or in combination with radiotherapy and chemotherapy
This paper explores how electric fields can help treat cancer. It shows that electric fields disrupt cancer cell division, making the cells die and stopping them from spreading. They also enhance the immune systems ability to fight cancer and improve the delivery of cancer drugs by making cell membranes more permeable. Electric fields affect important pathways that cancer cells use to grow, making them more sensitive to treatments. When used with radiotherapy or chemotherapy, electric fields can make these treatments work better. Overall, the study highlights that electric fields can be a powerful addition to cancer therapy, offering multiple ways to fight the disease and improve patient outcomes.
Educate, not kill: treating cancer without triggering its defenses
This paper highlights the limitations of traditional cytotoxic therapies and the emergence of resistant cells, leading to therapy failure. Alternative therapeutic strategies, such as controlling cell dormancy, transdifferentiation therapy, normalizing the cancer microenvironment, and migrastatic therapy, are proposed as effective approaches to re-educate cancer cells towards a less malignant phenotype. These strategies aim to avoid inducing direct proliferative advantages to resistant cells, thereby delaying or preventing the development of therapy-resistant tumors. Therefore, alternative therapies are crucial for improving cancer treatment outcomes.
Alternating Electric Fields in Glioblastomas: Past, Present, and Future
Alternating electric fields is a new and noninvasive treatment method for glioblastomas, a type of deadly brain cancer. This therapy has shown promising results, including prolonged survival for patients and manageable side effects. It works by strengthening the body’s own immune response against the tumor, increasing the permeability of cell membranes and the blood-brain barrier, and disrupting the processes that repair DNA damage in cancer cells. However, despite these promising results, the acceptance of alternating electric fields in everyday clinical practice is still low. The paper calls for more studies and discussions to better understand the potential of alternating electric fields and to address any concerns that may be limiting its use in real-world settings. In simple terms, alternating electric field is a promising new treatment for a type of brain cancer, but more work needs to be done to make it a common practice in clinics. It’s an exciting development in effective cancer treatment, but as with all new treatments, it’s important to continue researching and understanding its full potential and limitations.
Alternating Electric Fields Therapy Concomitant with Taxanes for Cancer Treatment
Certain types of cancers, like non-small cell lung cancer, ovarian cancer, and pancreatic cancer, are often treated with chemotherapy. However, these treatments can cause harmful side effects. There’s a need for additional therapies that can improve the effectiveness of these treatments without increasing the side effects. One such therapy is alternating electric field, which uses electric fields to disrupt the growth of cancer cells. The study suggests that using electric field therapy along with chemotherapy could potentially improve cancer treatment effectiveness without increasing side effects. This could be a promising step forward in an effective cancer treatment.
Disruption of Cancer Cell Replication by Alternating Electric Fields
Electric fields hold potential as a therapy for cancer, particularly for blood cancers characterized by spherical suspended cells. The paper elucidates how electric fields can disrupt the cell division process, inflicting damage on cancer cells. This study aims to encourage further research and advancements in electrostatic therapy, presenting a non-invasive, cost-effective, and targeted alternative to conventional treatments.
Electrical Characterization of Normal and Cancer Cells
The study delves into a captivating investigation aiming to differentiate between normal and cancer cells within liver, lung, and breast tissues. Using a set of parameters based on capacitance-voltage, researchers pinpointed unique electrical signatures for these cells. This pioneering method introduces novel prospects for recognizing and distinguishing normal and cancer cells based on their individual electrical signals. These findings offer potential advancements in diagnostic techniques, enhancing our capability to differentiate between healthy and cancerous cells across various tissue types.
Calculation of Externally Applied Electric Field Intensity for Disruption of Cancer Cell Proliferation
Electric fields present a promising avenue for cancer therapy, particularly for blood cancers characterized by spherical suspended cells. The paper elucidates how these fields can disrupt the cell division process, inflicting harm on cancerous cells. This study aims to stimulate further exploration and advancement in electrostatic therapy, envisioning a non-invasive, cost-effective, and targeted alternative to traditional treatments.
An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
Recent advancements of alternating electric fields therapy demonstrate potential in prolonging survival without the common side effects associated with traditional chemotherapy. This presents a promising prospect for a treatment that is both more effective and easier for patients to tolerate. As research continues, the idea of combining alternating electric field with other anti-cancer approaches emerges as a potential strategy to further boost effectiveness. Understanding these developments is essential for patients, caregivers, and the broader community, instilling hope and encouraging support for ongoing research aimed at improving outcomes for individuals with glioblastoma.
Permeabilizing Cell Membranes with Electric Fields
Alternating electric fields therapy stands as a promising non-invasive and effective cancer treatment, known for its minimal side effects. This innovative therapy disrupts cancer cell division without inducing considerable systemic toxicity, presenting a hopeful avenue for a more manageable and potent approach to cancer treatment.
The schemes, mechanisms and molecular pathway changes of Electric Field
This research emphasizes the potential of electric fields in combating cancer cells by disrupting their functions, leading to cell death and inhibiting their growth. The efficacy of this treatment hinges on several factors, including the frequency, intensity, duration, and direction of the electric field. Furthermore, when combined with other treatments like radiotherapy or chemotherapy, electric fields often exhibit a synergistic effect, enhancing their overall effectiveness. Overall, this offers a new ray of hope, particularly for patients whose cancers show resistance to traditional treatment methods.
Alternating Electric Fields: a new frontier in cancer therapy
Alternating electric fields therapy stands as a promising non-invasive and effective cancer treatment, known for its minimal side effects. This innovative therapy disrupts cancer cell division without inducing considerable systemic toxicity, presenting a hopeful avenue for a more manageable and potent approach to cancer treatment.
Alternating Electric Fields Technology: Alternating Electric Field Therapy for the Treatment of Solid Tumors
alternating electric fields therapy offer a novel strategy in combating cancer by utilizing electric fields. They possess the capability to halt the growth and spread of cancer cells while preserving normal cells from harm. Electric field are user-friendly, entail minimal side effects, and complement other treatment modalities effectively.
Alternating Electric Fields: A Fourth Modality in Cancer Treatment
Electric Field based Tumor-treating fields represent a promising, novel approach in an effective cancer treatment, employing electric fields to specifically target cancer cells while sparing normal ones. These fields are non-invasive, yield minimal side effects, and when combined with other therapies, show potential to enhance treatment outcomes.
How Do Alternating Electric Fields Work?
Scientists have devised a novel approach to an effective cancer treatment using electric fields. These fields, though extremely mild, have no detrimental impact on healthy cells; however, they possess the ability to impede the growth and division of cancer cells by influencing their internal structures. Administering these electric fields to the tumor site involves a device capable of adjusting the strength and orientation of the fields based on the cancer type. Extensive testing in both animals and humans across various cancer types has demonstrated favorable outcomes, including tumor reduction, extended survival rates, and improved patient quality of life. Notably, these electric fields have minimal side effects and synergize effectively with other treatments like surgery, chemotherapy, and radiation therapy. They possess a unique mechanism for eliminating cancer cells, distinct from conventional treatments, and can be tailored to target specific cancer cell types.
Research Progress on the Mechanism of Anti-Tumor Immune Response Induced by Alternating Electric fields
Cancer is a deadly disease that affects millions of people worldwide. Many treatments have been developed to fight cancer, but they often have serious side effects or limited effectiveness. A new technology uses electric fields to stop cancer cells from growing and spreading. Researchers have found that alternating electric field not only kill cancer cells directly, but also activate the body’s own immune system to fight cancer. This is important because the immune system can recognize and destroy cancer cells that escape other treatments. This review summarizes the current knowledge on this topic and discusses the potential benefits and challenges of combining alternating electric field with other therapies that boost the immune system.
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors
Researchers have uncovered the effectiveness of low-intensity, intermediate-frequency alternating electric fields in halting the growth of cancer cells. This innovative method has undergone rigorous testing, proving successful in lab settings (in vitro), animal trials (in vivo), and even in a select group of human patients battling recurrent glioblastoma, a formidable brain tumor. The outcomes are nothing short of remarkable, revealing a substantial increase in the time to disease progression and overall survival rates, all while maintaining minimal side effects. This groundbreaking discovery not only offers hope for those facing challenging forms of cancer but also signifies a promising stride toward more effective and less intrusive treatment options.
Alternating electric fields can improve chemotherapy treatment efficacy in blood cancer cell U937 (non-adherent cells)
Revolutionary strides in an effective cancer treatment are unfolding through innovative methods. A recent study has unveiled a promising approach by combining alternating electric fields with the chemotherapy agent Daunorubicin, showcasing enhanced efficacy in treating blood cancer cells, particularly the non-adherent U937 cells. This cutting-edge technique selectively targets dividing cancer cells while sparing normal cells, potentially paving the way for reduced side effects in patients. It's crucial to acknowledge that these findings are preliminary, and further research is imperative to solidify their impact. As always, individuals are advised to consult their healthcare providers for personalized guidance based on their unique health circumstances. This research signifies a significant leap forward in the relentless pursuit of more effective and targeted cancer treatments.
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study
Advancements in alternating electric fields can significantly improve the survival rates of patients with metastatic non-small cell lung cancer (mNSCLC) who have not responded to platinum-based chemotherapy. This study shows that combining alternating electric field therapy with standard-of-care treatments can lead to better outcomes compared to standard-of-care treatments alone.
Research Progress on the Mechanism of Anti-Tumor Immune Response Induced by TTFields
The article reviews the progress of research on the mechanism of anti-tumor immune response induced by Tumor Treating Fields (TTFields). TTFields has been approved for the treatment of glioblastomas and malignant pleural mesotheliomas. It highlights that TTFields have shown promising effects as a monotherapy and in combination with chemotherapy, but the underlying mechanisms through, which TTFields exert their anticancer effects remain incompletely understood. Recent research suggests that inducing anti-tumor immune responses may be a key mechanism of the anticancer activity of TTFields, leading to several clinical trials exploring the combination of TTFields with tumor immunotherapy and achieving positive results.
The distinguishing electrical properties of cancer cells
This paper explores the unique electrical properties of cancer cells, shedding light on the complex network of factors that contribute to the development of cancer. It challenges the
traditional view of cancer as solely a genetic disease and emphasizes the importance of understanding the electrostatic changes in cancer cells compared to normal cells. By exploring the
effects of alterations in intracellular and extracellular pH, changes in ionic concentrations, variations in transmembrane potential, and modifications within mitochondria, the paper provides a comprehensive understanding of the electrical landscape of cells. Additionally, it discusses the potential implications of these electrical properties for novel and effective cancer treatment modalities, such as electromagnetic field-based therapies. The research aims to pave the way for a new paradigm in understanding the role of electrical properties in health and disease, with the potential to revolutionize therapeutic interventions.
Electric Fields combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro
This paper demonstrate multimodal treatment approach combining electric fields and the drug repurposing strategy CUSP9v3 shows promising results in enhancing the anti-glioblastoma activity. The study provides evidence of the synergistic effects of electric fields and CUSP9v3 in inhibiting the growth and migration of glioblastoma cells. Additionally, the combination treatment was associated with the suppression of oxidative phosphorylation, a key feature of cancer cell metabolism. These findings suggest that the multimodal approach may offer a potential strategy for improving treatment outcomes for glioblastoma patients. The study also highlights the need for further research and potential transition to the clinical setting.
Electric Fields therapy in patients with glioblastoma: Long-term survival results in Germany in routine clinical care (TIGER) study.
Electric Fields therapy has demonstrated significant improvements in overall survival (OS) and progression-free survival (PFS) when applied with adjuvant temozolomide (TMZ) compared to TMZ alone in newly diagnosed glioblastoma (ndGBM). Electric Fields therapy delivers electric fields, through scalp-placed arrays, that disrupt cellular processes critical for cancer cell viability, is CE marked for WHO grade 4 glioma, and is a recommended treatment regimen for ndGBM. Electric Fields therapy was administered to >25,000 patients, showing no systemic toxicities and mild to moderate skin reactions being the main therapy-related adverse event. Here, the report survival and safety data from the TIGER study, the largest prospective study investigating real-world use of TTFields therapy during routine clinical care in patients with ndGBM in Germany.
Electric fields increase cytotoxic degranulation of natural killer cells against cancer cells
The study by Mylod et al. (2024) investigates the effects of electric fields, a non-invasive treatment using low-intensity, intermediate-frequency alternating electric fields, on natural killer (NK) cells and their ability to target glioblastoma (GBM) cells. The researchers found that electric fields, particularly at 200 kHz, significantly enhanced NK cell degranulation, a marker of cytotoxicity, against both K562 target cells and GBM cell lines without affecting NK cell viability or cytokine (IFN-γ) production.
This suggests that combining electric fields with NK cell-based immunotherapy could improve the efficacy of GBM treatments by increasing NK cell-mediated tumor cell killing. While electric fields exposure reduced the cytokine-mediated upregulation of nutrient receptors on NK cells, it did not impact mitochondrial health or granzyme B expression. These findings highlight the potential of electric fields to augment NK cell immunotherapy for GBM, warranting further investigation into the mechanisms and long-term effects of this combination treatment in more complex models.
Alternating Electric Fields Therapy for the Treatments of Solid Tumours
This paper provides an extensive overview of electric fields technology, particularly its application in treating glioblastoma multiforme (GBM). Electric fields therapy is a non-invasive treatment that employs low-intensity, intermediate-frequency alternating electric fields to disrupt cancer cell division, leading to cell death while sparing normal cells. The therapy is administered through a wearable device, which patients can use at home, ensuring continuous treatment. Clinical trials have demonstrated the efficacy of electric fields in both recurrent and newly diagnosed GBM, showing comparable or superior outcomes to traditional chemotherapy with fewer side effects. Future research and clinical trials are exploring the application of electric fields in treating other types of solid tumors, with ongoing studies indicating promising synergistic effects when combined with other treatments like radiotherapy and immunotherapy. The paper underscores the importance of multidisciplinary care and continuous patient education to optimize the benefits of this innovative and effective cancer treatment technology.
Therapeutic potential of tumor treating fields for malignant brain tumors
GBM is among the most lethal and challenging cancers due to their high recurrence rates and resistance to conventional therapies. Despite advancements in surgery, chemotherapy, and radiation, the prognosis for GBM remains dismal, with a median survival of only 15 months and a 5- year survival rate below 5%. This highlights the urgent need for innovative treatments. Electric field-based therapies have emerged as a promising non-invasive therapeutic approach that leverages the unique bioelectrical properties of cancer cells to disrupt their growth and proliferation. Electric fields work by applying alternating electric fields at specific frequencies and intensities, which interfere with the bioelectrical state of macromolecules and organelles within cancer cells, leading to several anti-cancer effects. These include (1) inhibition of cell mitosis by disrupting the formation of microtubule spindles, which leads to mitotic arrest and cell death; (2) disruption of genomic integrity, which increases DNA damage and inhibits DNA repair mechanisms, thus contributing to cancer cell death; (3) suppression of cell migration and invasion by altering the cellular cytoskeleton and affecting ion channel activity, thereby hindering the metastatic potential of cancer cells; (4) induction of autophagy, where abnormal mitotic events can trigger cellular self- digestion processes leading to cell death; and (5) enhancement of the anti-tumor immune response by inducing the release of damage-associated molecular patterns that activate the immune system against the tumor.
Positive Electrostatic Therapy of Metastatic Tumors: Selective Induction of Apoptosis in Cancer Cells by Pure Charges (Cancer Medicine)
The study demonstrated that Positive Electrostatic Charges (PECs) could selectively induce apoptosis in breast cancer cell lines, including MCF-7 (hormone receptor-positive breast cancer) and MDA-MB-468 (triple-negative breast cancer) cells. The therapy showed significant reductions in cell viability, while normal breast epithelial cells (MCF-10A) were not adversely affected, highlighting the selectivity of PECs. The strong preclinical evidence, particularly the selectivity demonstrated in both cancerous (MCF-7, MDA-MB-468) and non-cancerous (MCF-10A) cells, supports the initiation of human trials. Successful human trials could lead to PEC being integrated into treatment protocols for various types of breast cancer.
Capture-free Deactivation of Circulating Tumor Cells in the Bloodstream by Positive Electrostatic Charges: A Metastasis Suppression Method (Biosensors and Bioelectronics) in an Effective Cancer Treatment
The study demonstrated that PECs could effectively deactivate circulating tumor cells (CTCs) in the bloodstream. The efficacy of PECs was evaluated using both in vitro and in vivo models, including human metastatic breast cancer cell lines (MDA- MB-231) and mouse mammary carcinoma cell lines (4T1). PECs present a new, non-invasive method for preventing metastasis by targeting and deactivating CTCs in the bloodstream before they can establish secondary tumors. This approach could be particularly valuable for patients with aggressive cancers, where early intervention can prevent the spread of the disease and improve survival outcomes. While the study primarily focused on breast cancer models, the principles behind PECs suggest it could be applied to a wide range of cancers where metastasis is a major concern. This broad applicability makes PECs a potentially transformative tool in oncology, offering a new line of defense against the spread of cancer.
Human Pilot Study on Positive Electrostatic Charge Effects as an Effective Cancer Treatment in Solid Tumors of Late-Stage Metastatic Patients (Frontiers in Medicine)
This human pilot study involved 41 patients with late-stage metastatic cancer, all with solid tumors that were unresponsive to conventional therapies such as chemotherapy and radiotherapy. These patients were considered for Positive Electrostatic Charge Therapy (PECT) as a last resort. Over 80% of the patients exhibited a measurable reduction in tumor size, with some tumors shrinking by more than 50%. This significant reduction occurred without disease progression during the treatment period. For patients who did not experience significant shrinkage, the disease was stabilized, with no further tumor growth observed. Patients reported relief from various cancer-related symptoms, such as pain and fatigue, leading to an overall improvement in quality of life. Some patients also experienced improved mobility and daily functioning. For patients with late-stage metastatic cancer who have no other treatment options, PECT offers a potentially effective and safe alternative, extending life and improving quality of life.
Effective Cancer Treatment Breakthrough: Using Electric Charges to Fight Tumors
Scientists have discovered a promising new way to treat cancer using Positive Electrostatic Charges (PECs). This method uses electric charges to target and kill cancer cells while leaving healthy tissues unharmed. Cancer cells behave differently from normal cells, they have unique surface charges and disrupted metabolic pathways. PECs take advantage of these differences by applying a gentle electric charge to cancer cells. This disrupts the cells' processes, leading to their death, without harming normal cells. PECs work by triggering natural cell death (apoptosis) in cancer cells without causing the inflammation or tissue damage seen in other treatments. This makes it highly selective, effective, and free of major side effects.
A New Hope in an Effective Cancer Treatment: Harnessing Positive Electrostatic Charge Therapy
Electric field therapy represents a groundbreaking advancement in an effective cancer treatment, offering hope to patients with advanced-stage cancers. This non-invasive approach uses positively charged patches applied near tumors to selectively target cancer cells while sparing healthy tissues. By exploiting the unique electrical properties of cancer cells, such as their abnormal surface charges and membrane structures, this therapy disrupts their function and signals, ultimately leading to self-destruction without harming surrounding healthy cells. Clinical trials have shown promising results: patients treated with electric field therapy experienced up to 70% tumor shrinkage in several cases, with complete remission observed in approximately 30% of advanced breast cancer and liver metastasis patients. These outcomes far exceeded those achieved with conventional therapies like chemotherapy and radiation. In clinical studies, 80% of patients reported a reduction in cancer-related symptoms such as pain and swelling, while regaining strength to pursue additional treatments like surgery.
Electric Field Therapy: A Non-Invasive Breakthrough for Brain Cancer Treatment
Brain cancer, particularly glioblastoma (GBM), remains one of the most challenging and lethal diseases, with limited treatment options and harsh side effects. Clinical research shows that electric field therapy can significantly extend survival when combined with standard treatments like chemotherapy or radiation. It also enhances the effectiveness of these therapies by making it easier for cancer drugs to reach the tumor. Importantly, electric field therapy has far fewer side effects compared to chemotherapy or radiation alone. Patients report better quality of life, longer survival, and greater independence.
Cancer Cell Permeability Induced by Alternating Electric Fields as a Physical Approach to Improve Chemotherapy Uptake and Overcome Multidrug Resistance
Researchers have discovered that a non-invasive electric field treatment can help chemotherapy work better against cancer—even in cases where the cancer has become resistant to drugs. The study showed that electric fields make cancer cells more “leaky” during cell division, allowing more chemotherapy medicine to enter the cells. This effect was seen in lab tests and in animals with breast and lung tumors. Importantly, the electric field did not harm healthy cells and could help overcome one of the biggest challenges in an effective cancer treatment: when tumors stop responding to medicine.
Enhancing Immunotherapy in Glioblastoma: New Hope Through Electric Field Therapy
In a recent study published in Cell Medicine, researchers explored the potential of combining electric field therapy with the immunotherapy drug pembrolizumab to improve treatment outcomes for patients with glioblastoma, an aggressive and treatment-resistant form of brain cancer. The study found that patients who received both electric field therapy and pembrolizumab experienced a significantly longer progression-free survival (PFS) compared to those treated with immunotherapy alone, all while maintaining manageable safety profiles. On a biological level, the electric field appeared to enhance immune system activity by boosting antigen presentation and promoting T-cell infiltration into tumors. This synergistic effect with pembrolizumab suggests that electric field therapy may help overcome immune resistance in glioblastoma, marking a promising advancement in the development of more effective treatment strategies.
Anti-cancer mechanisms of action of therapeutic alternating electric fields
This innovative approach uses low-intensity alternating electric fields to target and disrupt cancer cells, offering new hope, especially for aggressive solid organ cancers like glioblastoma and pancreatic cancer. The research reveals that electric fields interfere with various fundamental processes within cancer cells, including disrupting their internal structures, altering cell membrane permeability, and crucially, impeding their ability to divide and multiply. Furthermore, electric field can hinder cancer's spread by reducing cell migration and the formation of new blood vessels, while also potentially improving drug delivery to tumors by increasing the permeability of the blood-brain barrier. This comprehensive understanding of electric fields' mechanisms is vital for optimizing its use and developing even more effective combination therapies in our ongoing fight against cancer.
bottom of page